Phase 3 Results for Dymista for Allergic Rhinitis - ONA
Links shared publicly online about this topic.
- 217total visits
Phase 3 Results for Dymista for Allergic Rhinitis - ONA
View full resource at oncologynurseadvisor.com
Tags: Allergies, Seasonal Allergy, Asthma Medication, COPD Medication, Phase 3 Clinical Trial, Flovent, Flixotide, Flonase
Most Recently Shared on June 15, 2011 at 3:03 pm By:
Phase 3 Results for Dymista for Allergic Rhinitis http://goo.gl/fb/hqibE
Meda: Positive Study Results Presented For Dymista
medicalnewstoday.com — “Meda (STO:MEDAA) announced positive results from a Phase III clinical trial of Dymista (also known as MP29-02), a novel formulation of azelastine hydrochloride and fluticasone propionate, in patie” View full resource at medicalnewstoday.com
Most Recently Shared on March 23, 2011 at 12:05 pm By:
MNT Ear, Nose Throat Health News
Meda: Positive Study Results Presented For Dymista http://mnt.to/3SCB #entnews
Phase 3 Study of Dymista for Seasonal Allergic Rhinitis - MPR
empr.com — “Meda announced positive results from its Phase 3 trial of Dymista (azelastine HCl and fluticasone propionate) nasal spray in patients with seasonal allergic rhinitis” View full resource at empr.com
Most Recently Shared on March 22, 2011 at 6:08 pm By:
MPR News: Phase 3 Study of Dymista for Seasonal Allergic Rhinitis: Meda announced positive results from its Phas... http://bit.ly/hpduGL
Nuvo Research Announces Positive Top-Line Wf10 Phase 2 Trial Results - Drugs.com MedNews
drugs.com — “European Phase 2 Clinical Trial Evaluating WF10 as a Treatment for Severe Allergic Rhinitis Meets its Primary Endpoint MISSISSAUGA, ON, Nov. 8 PRNewswire - Nuvo” View full resource at drugs.com
Most Recently Shared on November 9, 2010 at 5:16 pm By:
Drugs and Devices OW OW Health
Nuvo Research Announces Positive Top-Line Wf10 Phase 2 Trial Results: European Phase 2 Clinical Trial Eval... http://bit.ly/ao5Ur3 #drug
Sepracor Reports Preliminary Results From A Second Phase III Study For OMNARIS(R) HFA Nasal Aerosol In Seasonal Allergic Rhinitis
medicalnewstoday.com — “Sepracor Inc. announced the preliminary results of a large-scale, 671-patient Phase III study of OMNARIS® (ciclesonide) HFA, an aerosol nasal formulation of ciclesonide, for the treatment of” View full resource at medicalnewstoday.com
Most Recently Shared on July 4, 2010 at 10:20 am By:
Sepracor Reports Preliminary Results From A Second Phase III Study For OMNARIS(R) HFA Nasal Aerosol In Seasonal Allerg... http://mnt.to/3FHr
STALLERGENES: Persistent Efficacy Demonstrated After A Year On Actair(R) Followed By A Second Treatment-Free Year
medicalnewstoday.com — “After having announced positive results for the first year of its phase IIb/III clinical trial (VO 57.07) conducted on Actair(R) sublingual allergen immunotherapy tablets in allergic rhinitis trig” View full resource at medicalnewstoday.com
Most Recently Shared on June 29, 2010 at 11:22 am By:
STALLERGENES: Persistent Efficacy Demonstrated After A Year On Actair(R) Followed By A Second Treatment-Free Year http://mnt.to/3Ftw
Advertisement
